Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$3.54

0.09 (2.61%)

08:37
05/24/19
05/24
08:37
05/24/19
08:37

BioCryst downgraded to Sector Perform at RBC Capital on disappointing '7353 data

As previously reported, RBC Capital analyst Brian Abrahams downgraded BioCryst to Sector Perform from Outperform and lowered his price target to $4.50 from $16. The analyst cites the "disappointing" efficacy data for BCX7353, relegating the drug's potential to a "smaller niche role" even with discount pricing. Abrahams adds that although approvability risks for '7353 may be unfounded and the stock may bounce, he believes that the Street will have to turn more confident about its future revenues to offset the investments in filing and commercialization.

  • 29

    May

BCRX BioCryst
$3.54

0.09 (2.61%)

05/24/19
RBCM
05/24/19
DOWNGRADE
Target $4.5
RBCM
Sector Perform
BioCryst downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Brian Abrahams downgraded BioCryst Pharmaceuticals to Sector Perform from Outperform and lowered his price target for the shares to $4.50 from $16.
05/23/19
JMPS
05/23/19
NO CHANGE
Target $10
JMPS
Outperform
BioCryst price target lowered to $10 from $18 at JMP Securities
JMP Securities analyst Liisa Bayko maintains an Outperform rating on BioCryst Pharmaceuticals after her talks with two key opinion leader doctors supported her view that HAE patients will want to try an oral option and BCX7353 could be "good enough" for a substantial proportion of them. However, she cut her price target on the shares to $10 from $18 to account for the fact that she lowered her U.S. launch price estimate to $250,000 from $500,000 annually.
05/22/19
JEFF
05/22/19
NO CHANGE
Target $8
JEFF
Buy
BioCryst price target lowered to $8 from $13 at Jefferies
Jefferies analyst Maury Raycroft lowered his price target for BioCryst Pharmaceuticals to $8 from $13 while keeping a Buy rating on the shares. The analyst still believes BCX7353 gets approved and used in the prophy setting, but he admits that use may be more limited with more reliance on pricing strategies following yesterday's Phase 3 data.
05/22/19
JPMS
05/22/19
NO CHANGE
Target $5
JPMS
Overweight
JPMorgan halves BioCryst target to $5, sees share upside over time
JPMorgan analyst Jessica Fye lowered her price target for BioCryst Pharmaceutical to $5 from $10 saying the topline Phase III results for APeX-2 remove both the best-case and worst-case scenarios for BCX7353. The safety data removed a key downside risk, but BCX7353 will probably not be as large as it might have been with better efficacy, Fye tells investors in a research note. The analyst now models peak prophylaxis sales of ~$300M. However, she still sees share upside over time following yesterday's selloff and maintains an Overweight rating on BioCryst.

TODAY'S FREE FLY STORIES

SMH

Market Vectors Semiconductor

$107.34

0.235 (0.22%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMP

Immutep

$1.78

-0.065 (-3.52%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Hot Stocks
Immutep completes patient enrollment for AIPAC trial »

Immutep announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$188.18

0.0256 (0.01%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Conference/Events
Sandler O'Neill to hold a forum »

Student Housing REIT…

YUM

Yum! Brands

$110.62

0.35 (0.32%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Initiation
Yum! Brands initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
06/25/19
06/25
08:16
06/25/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMTV

Hemisphere Media

$12.53

-0.27 (-2.11%)

, LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

08:15
06/25/19
06/25
08:15
06/25/19
08:15
Conference/Events
Bernstein to hold a summit »

6th Annual Bernstein…

HMTV

Hemisphere Media

$12.53

-0.27 (-2.11%)

LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

NXST

Nexstar

$99.89

-1.83 (-1.80%)

OUT

Outfront Media

$26.85

0.33 (1.24%)

LIVX

LiveXLive Media

$4.25

0.23 (5.72%)

NLSN

Nielsen

$22.34

-1.08 (-4.61%)

EROS

Eros International

$2.37

(0.00%)

WWE

WWE

$73.15

-0.33 (-0.45%)

OPRA

Opera

$11.10

-0.46 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 13

    Nov

RARX

RA Pharmaceuticals

$26.19

0.69 (2.71%)

, EXEL

Exelixis

$20.73

-0.66 (-3.09%)

08:15
06/25/19
06/25
08:15
06/25/19
08:15
Conference/Events
BMO Capital to hold a conference »

Prescriptions for Success…

RARX

RA Pharmaceuticals

$26.19

0.69 (2.71%)

EXEL

Exelixis

$20.73

-0.66 (-3.09%)

MNK

Mallinckrodt

$8.42

-0.54 (-6.03%)

IRTC

iRhythm

$78.16

-1.43 (-1.80%)

ANTM

Anthem

$290.47

-3.06 (-1.04%)

BHC

Bausch Health

$23.76

-0.06 (-0.25%)

RTRX

Retrophin

$20.29

-0.18 (-0.88%)

PEN

Penumbra

$164.40

-0.3 (-0.18%)

SQST

Sciquest.com

$0.00

(0.00%)

SILK

Silk Road Medical

$47.02

0.03 (0.06%)

NEOS

Neos Therapeutics

$1.16

0.005 (0.43%)

TCRR

TCR2 Therapeutics

$14.78

-0.86 (-5.50%)

CNST

Constellation Pharmaceuticals

$9.26

-0.94 (-9.22%)

MITO

Stealth Biotherapeutics

$12.95

(0.00%)

FPRX

Five Prime

$6.14

-0.18 (-2.85%)

EBS

Emergent BioSolutions

$45.68

-0.7 (-1.51%)

AGLE

Aeglea BioTherapeutics

$6.36

-0.15 (-2.30%)

OBSV

ObsEva

$11.24

-0.32 (-2.77%)

IMUX

Immunic

$17.50

7.79 (80.23%)

PTGX

Protagonist Therapeutics

$11.84

-0.19 (-1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jun

  • 26

    Aug

CMG

Chipotle

$724.14

-3.035 (-0.42%)

08:13
06/25/19
06/25
08:13
06/25/19
08:13
Initiation
Chipotle initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

PZZA

Papa John's

$44.13

-0.25 (-0.56%)

08:11
06/25/19
06/25
08:11
06/25/19
08:11
Initiation
Papa John's initiated  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GNFT

Genfit

$20.19

-0.02 (-0.10%)

08:10
06/25/19
06/25
08:10
06/25/19
08:10
Initiation
Genfit initiated  »

Genfit initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

08:10
06/25/19
06/25
08:10
06/25/19
08:10
Hot Stocks
Bombardier to sell Canadair regional jet program to MHI for $550M »

Mitsubishi Heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$70.30

0.295 (0.42%)

08:09
06/25/19
06/25
08:09
06/25/19
08:09
Initiation
Restaurant Brands initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$267.20

-3.19 (-1.18%)

08:08
06/25/19
06/25
08:08
06/25/19
08:08
Hot Stocks
Humana enters collaboration with Aspen RxHealth »

Aspen RxHealth announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 13

    Nov

ACLS

Axcelis

$14.32

-0.18 (-1.24%)

08:08
06/25/19
06/25
08:08
06/25/19
08:08
Hot Stocks
Axcelis awarded first order for new Purion XE Power Series implanter »

Axcelis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 07

    Aug

PHG

Philips

$42.92

-0.18 (-0.42%)

08:07
06/25/19
06/25
08:07
06/25/19
08:07
Hot Stocks
Philips enters collaboration with BioBright »

BioBright announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$71.45

4.64 (6.95%)

08:07
06/25/19
06/25
08:07
06/25/19
08:07
Recommendations
Match Group analyst commentary at Jefferies »

Jefferies sees 'no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAT

ViaSat

$82.88

-0.59 (-0.71%)

, TDY

Teledyne

$266.52

1.625 (0.61%)

08:06
06/25/19
06/25
08:06
06/25/19
08:06
Hot Stocks
ViaSat and Teledyne Controls announce partnership »

Viasat (VSAT) and…

VSAT

ViaSat

$82.88

-0.59 (-0.71%)

TDY

Teledyne

$266.52

1.625 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNKN

Dunkin' Brands

$81.01

1.47 (1.85%)

08:06
06/25/19
06/25
08:06
06/25/19
08:06
Initiation
Dunkin' Brands initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

TROV

Trovagene

$2.57

0.045 (1.78%)

08:05
06/25/19
06/25
08:05
06/25/19
08:05
Syndicate
Breaking Syndicate news story on Trovagene »

Trovagene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

HALO

Halozyme

$16.11

-0.34 (-2.07%)

08:04
06/25/19
06/25
08:04
06/25/19
08:04
Hot Stocks
Halozyme announces CRADA with VRC for use of ENHANZE technology »

Halozyme Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBM

Cambrex

$44.20

-0.01 (-0.02%)

, CMD

Cantel Medical

$75.43

-0.75 (-0.98%)

08:04
06/25/19
06/25
08:04
06/25/19
08:04
Hot Stocks
Cambrex appoints Dottie Donnelly-Brienza CHRO »

Cambrex (CBM) announced…

CBM

Cambrex

$44.20

-0.01 (-0.02%)

CMD

Cantel Medical

$75.43

-0.75 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MET

MetLife

$49.09

0.17 (0.35%)

08:04
06/25/19
06/25
08:04
06/25/19
08:04
Periodicals
MetLife in talks to sell Hong Kong insurance unit to FWD, Bloomberg reports »

MetLife is in advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NANO

Nanometrics

$34.31

0.51 (1.51%)

, RTEC

Rudolph Technologies

$27.43

2.42 (9.68%)

08:03
06/25/19
06/25
08:03
06/25/19
08:03
Recommendations
Nanometrics, Rudolph Technologies analyst commentary at Benchmark »

Nanometrics deal for…

NANO

Nanometrics

$34.31

0.51 (1.51%)

RTEC

Rudolph Technologies

$27.43

2.42 (9.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.